Vemlidy 25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1QBT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,693
Award facts
- Contract value 100% obligated
- $3,693.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,693.37 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count packaging) on January 20, 2026, with an ultimate completion date of January 21, 2026. This non-set-aside, firm fixed-price delivery order was awarded competitively and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00 and running through December 31, 2031, serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The performance location for this delivery order is the company's corporate office in Conshohocken, Pennsylvania.
Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing one of many specialized pharmaceutical products that AmerisourceBergen supplies through its federal contract portfolio. As a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems, AmerisourceBergen maintains a diverse portfolio of federal contracts covering medications across multiple therapeutic domains. This delivery order exemplifies the company's role in fulfilling federal medical supply requirements through the DLA's pharmaceutical supply chain, supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1QBT?
SPE2DR26F1QBT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1QBT worth?
The government has obligated $3,693 on SPE2DR26F1QBT.
Is contract SPE2DR26F1QBT an order under another contract?
Yes. SPE2DR26F1QBT is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1QBT competed?
The extent of competition for SPE2DR26F1QBT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award